Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Jefferies analyst Tycho Peterson upgraded the rating for GeneDx Holdings Corp. WGS from Hold to Buy and announced a target of $80. GeneDx shares closed at $56.36 on Thursday. See how other analysts view this stock.
- Citigroup analyst Paul Lejuez upgraded the rating for National Vision Holdings, Inc. EYE from Neutral to Buy and raised the price target from $13 to $21. National Vision shares closed at $16.68 on Thursday. See how other analysts view this stock.
- B of A Securities analyst Tazeen Ahmad upgraded PTC Therapeutics, Inc. PTCT from Neutral to Buy and raised the price target from $55 to $68. PTC Therapeutics shares closed at $42.51 on Thursday. See how other analysts view this stock.
Considering buying EYE stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
